MAGELLAN HEALTH INC's ticker is MGLN and the CUSIP is 559079207. A total of 203 filers reported holding MAGELLAN HEALTH INC in Q2 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $704,000 | +10.0% | 8,499 | +0.6% | 0.01% | 0.0% |
| Q3 2020 | $640,000 | +5.1% | 8,451 | +1.3% | 0.01% | -7.7% |
| Q2 2020 | $609,000 | +66.8% | 8,343 | +10.0% | 0.01% | +44.4% |
| Q1 2020 | $365,000 | -38.6% | 7,585 | 0.0% | 0.01% | -25.0% |
| Q4 2019 | $594,000 | +29.7% | 7,585 | +2.9% | 0.01% | +20.0% |
| Q3 2019 | $458,000 | -23.2% | 7,374 | -8.1% | 0.01% | -23.1% |
| Q2 2019 | $596,000 | +17.6% | 8,026 | +4.5% | 0.01% | +30.0% |
| Q1 2019 | $507,000 | +18.5% | 7,684 | +2.0% | 0.01% | -9.1% |
| Q4 2018 | $428,000 | -18.3% | 7,532 | +3.5% | 0.01% | 0.0% |
| Q3 2018 | $524,000 | -23.2% | 7,276 | +2.3% | 0.01% | -26.7% |
| Q2 2018 | $682,000 | -5.7% | 7,112 | +5.4% | 0.02% | -11.8% |
| Q1 2018 | $723,000 | +19.7% | 6,748 | +7.9% | 0.02% | +21.4% |
| Q4 2017 | $604,000 | +16.6% | 6,253 | +4.3% | 0.01% | +7.7% |
| Q3 2017 | $518,000 | +21.6% | 5,998 | +2.5% | 0.01% | +18.2% |
| Q2 2017 | $426,000 | +11.8% | 5,849 | +6.0% | 0.01% | +10.0% |
| Q1 2017 | $381,000 | -0.3% | 5,518 | +8.6% | 0.01% | 0.0% |
| Q4 2016 | $382,000 | +40.4% | 5,079 | +0.4% | 0.01% | +25.0% |
| Q3 2016 | $272,000 | -14.2% | 5,060 | +5.1% | 0.01% | -11.1% |
| Q2 2016 | $317,000 | +6.4% | 4,813 | +9.5% | 0.01% | 0.0% |
| Q1 2016 | $298,000 | +17.3% | 4,394 | +6.6% | 0.01% | +12.5% |
| Q4 2015 | $254,000 | +14.9% | 4,122 | +3.6% | 0.01% | +14.3% |
| Q3 2015 | $221,000 | -16.6% | 3,980 | +5.4% | 0.01% | -12.5% |
| Q2 2015 | $265,000 | +5.6% | 3,775 | +6.6% | 0.01% | 0.0% |
| Q1 2015 | $251,000 | +17.8% | 3,541 | -0.4% | 0.01% | +700.0% |
| Q4 2014 | $213,000 | +8.1% | 3,556 | -1.1% | 0.00% | -50.0% |
| Q3 2014 | $197,000 | -8.8% | 3,596 | +3.8% | 0.00% | 0.0% |
| Q2 2014 | $216,000 | +8.5% | 3,464 | +3.2% | 0.00% | 0.0% |
| Q1 2014 | $199,000 | -22.9% | 3,355 | -22.1% | 0.00% | 0.0% |
| Q4 2013 | $258,000 | +8.9% | 4,305 | +9.1% | 0.00% | -33.3% |
| Q3 2013 | $237,000 | +12.3% | 3,947 | +5.1% | 0.00% | +50.0% |
| Q2 2013 | $211,000 | – | 3,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altalis Capital Management LLC | 130,506 | $11,262,000 | 7.39% |
| Hudson Executive Capital LP | 197,400 | $17,036,000 | 4.28% |
| Hood River Capital Management LLC | 507,355 | $43,785,000 | 2.78% |
| Hillcrest Asset Management LLC | 102,230 | $8,822,000 | 1.60% |
| Dean Capital Management | 38,719 | $3,341,000 | 1.56% |
| Smith, Graham & Co., Investment Advisors, LP | 151,061 | $13,037,000 | 1.37% |
| DEAN INVESTMENT ASSOCIATES, LLC | 56,950 | $4,915,000 | 0.75% |
| Orbimed Advisors | 882,600 | $76,168,000 | 0.73% |
| Aviance Capital Partners, LLC | 22,200 | $1,916,000 | 0.65% |
| Alambic Investment Management, L.P. | 63,413 | $5,473,000 | 0.60% |